Market Capitalization: TransMedics Group (TMDX)

TransMedics Group (TMDX) generates revenue through the sale of mobile organ preservation systems and associated consumables. The company mitigates operational risks by developing its own aviation logistics and expanding the range of supported organs. The current metric stands at 3.20. Due to patent protection and strict FDA regulations, the company maintains a monopoly, as evidenced by the price trajectory of the securities shown below.

TMDX (transmedics.com) Market Capitalization history from 07/04/2022 to 11/12/2026

Financial and market metric breakdowns for TransMedics Group Inc (TMDX)

- market price and analyst price targets:

Price Chart TransMedics|TMDX - Consensus Target

- company stock exchange capitalization indicators:

Market Capitalization TransMedics Organ Care System|TMDX - Business Value

- issuer book value statistics:

Accounting Value per Share TransMedics|TMDX - Accounting Capitalization|Market Value to Book Value Ratio transmedics.com|TMDX - Company Total Asset Base

- company total debt and liquidity indicators:

- net income and valuation multiples indicators:

TMDX - Net Profit|Expected Profit TransMedics Group|TMDX - Price to Earnings Ratio|Forward P/E Multiple transmedics.com|TMDX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio TransMedics Organ Care System|TMDX - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) TransMedics|TMDX - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth transmedics.com|TMDX - Earnings per share growth this year|Expected earnings per share growth for next year TransMedics Group

Initial company analysis:TransMedics Group TMDX

Original product of TransMedics Group Inc

Market capitalization reflects the total value of equity through the balance of supply and demand, determining the real-time market valuation of the business. The current market capitalization of TransMedics Group (TMDX) confirms investor confidence in the expansion rates of organ preservation systems and logistical precision, transforming high revenue growth into sustainable investment attractiveness for the asset.

Competitors of TransMedics Group (TMDX)